Scientific authorship, pluralism, and practice

Accountability in Research

Volumn 25, Issue 4, 2018, Pages 199-211

  Moffatt, Barton ^a  

^a MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

Authorship; research ethics; scientific pluralism

Indexed keywords

CULTURAL DIVERSITY; ETHICS; HUMAN; MEDICAL RESEARCH; PROFESSIONAL PRACTICE; PUBLICATION; PUBLISHING; WRITING;

AUTHORSHIP; BIOMEDICAL RESEARCH; CULTURAL DIVERSITY; EDITORIAL POLICIES; HUMANS; PERIODICALS AS TOPIC; PROFESSIONAL AUTONOMY;

EID: 85042212395     PISSN: 08989621     EISSN: 15455815     Source Type: Journal    
DOI: 10.1080/08989621.2018.1437347     Document Type: Article

References (27)

1. Flanigan, A., L. A., Carey, P. B., Fontanarosa, S. G., Phillips, B. P., Pace, G. D., Lundberg, and D., Rennie. 1998. Prevalence of articles with honorary authors and ghost authors in peer reviewed medical journals. JAMA 280:222–24. doi:10.1001/jama.280.3.222.
2. Fugh-Berman, A., 2005. The corporate coauthor. Journal of General Internal Medicine 20:546–48. doi:10.1111/j.1525-1497.2005.05857.x.
3. Fugh-Berman, A., 2010. The haunting of medical journals: How ghostwriting sold “HRT”. PLoS Medicine 7 (9):e1000335. doi:10.1371/journal.pmed.1000335.
4. Gøtzsche, P. C., A., Hróbjartsson, H. K., Johansen, M. T., Haahr, D. G., Altman, and A., Chan. 2007. Ghost authorship in industry-initiated randomized trials. PLoS Medicine 4:e19. doi:10.1371/journal.pmed.0040019.
5. International Committee of Medical Journal Editors. 2013. Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publications. Accessed March30, 2013. http://www.icmje.org/.
6. International Committee of Medical Journal Editors. 2017. Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publications. Accessed December26, 2017. http://www.icmje.org/.
7. Kellert, S., H., Longino, and C. K., Waters, eds. 2006. Scientific pluralism (Minnesota studies in the philosophy of science, Vol. XIX). Minneapolis: University of Minnesota Press.
8. Le Noury, J., J. M., Nardo, D., Healy, J., Jureidini, M., Raven, C., Tufanaru, et al. 2015. Restoring study 329: Efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence. BMJ 351:h4320. doi:10.1136/bmj.h4320.
9. McHenry, L. B., and J., Jureidini. 2008. Industry-sponsored ghostwriting in clinical trial reporting: A case study. Accountability in Research 15 (3):152–67. doi:10.1080/08989620802194384.
10. Moffatt, B., 2007. Ghostwriting study needs clearer justification of criterion for authorship. online response to Gøtzsche P.C, Hróbjartsson A., Johansen H.K., Haahr, M.T., Altman, D.G., et al. 2007. “Ghost authorship in industry-initiated randomised trials.”. PLoS Medicine 4 (1):e19.
11. Moffatt, B., 2011. Responsible authorship: Why researchers must forgo honorary authorship. Accountability in Research 18 (2):76-90.
12. Moffatt, B., 2013. Orphan articles and ghostwriting: The case against the ICMJE criterion of authorship. Accountability in Research 20 (2):59–71. doi:10.1080/08989621.2013.767115.
13. Moffatt, B., and C., Elliott. 2007. Ghost marketing: Pharmaceutical companies and ghostwritten journal articles. Perspectives in Biology and Philosophy 50:18–31. doi:10.1353/pbm.2007.0009.
14. Mowatt, G., L., Shirran, J. M., Grimshaw, D., Rennie, A., Flanagin, V., Yank, G., MacLennan, P. C., Gøtzsche, and L. A., Bero. 2002. Prevalence of articles with honorary authors and ghost authors in Cochrane reviews. Jama 287:2769–71. doi:10.1001/jama.287.21.2769.
15. Neurology. 2013. Authorship definition. Accessed March30, 2013. http://www.neurology.org/site/misc/auth2.html#AUTHORSHIPDEFINTION.
16. Resnik, D. B., 1996. Social epistemology and the ethics of research. Studies in History and Philosophy of Science Part A 27 (4):565–86. doi:10.1016/0039-3681(96)00043-X.
17. Ross, J. S., K. P., Hill, D. S., Egilman, and H. M., Krumholz. 2008. Guest authorship and ghostwriting in publications related to rofecoxib: A case study of industry documents from rofecoxib litigation. JAMA 299:1800–12. doi:10.1001/jama.299.15.1800.
18. Seeman, J. I., and M. C., House. 2015. Authorship issues and conflict in the U.S. academic chemical community. Accountability in Research 22 (6):346–83. doi:10.1080/08989621.2015.1047707.
19. Shamoo, A., and D., Resnik. 2015. Responsible conduct of research. 3rd ed. New York: Oxford University Press.
20. Sismondo, S., 2007. Ghost management: How much of the medical literature is shaped behind the scenes by the pharmaceutical industry? PLoS Medicine 4 (9):e286. doi:10.1371/journal.pmed.0040286.
21. Sismondo, S., 2009. Ghosts in the machine publication planning in the medical sciences. Social Studies of Science 39:171–98. doi:10.1177/0306312708101047.
22. Smith, E., 2017. A theoretical foundation for the ethical distribution of authorship in multidisciplinary publications. Kennedy Institute Ethics Journal 27 (3):371–411. doi:10.1353/ken.2017.0032.
23. Trinkle, B., T., Phillips, A., Hall, and B., Moffatt. 2017. Neutralising fair credit: Factors that influence unethical authorship practices. Journal of Medical Ethics 43 (6):368–73. doi:10.1136/medethics-2015-103365.
24. University of Pittsburgh. 2006. Summary investigative report on allegations of possible scientific misconduct on the part of Gerald P. Schatten, Ph.D. Accessed December26, 2017. https://ecommons.cornell.edu/bitstream/handle/1813/11589/Gerald_Schatten_Final_Report_2.08.pdf?sequence=1&isAllowed=y.
25. Walsh, J., 2012. Medtronic’s pull influenced Infuse articles, report finds. Star Tribune. Accessed September15, 2013. http://www.startribune.com/lifestyle/health/175804281.html.
26. Wislar, J., A., Flanagin, P. B., Fontanarosa, and C. D., DeAngelis. 2011. Honorary and ghost authorship in high impact biomedical journals: Across sectional survey. BMJ 343:d6128. doi:10.1136/bmj.d6128.
27. World Association of Medical Editors. 2013. Criteria for authorship. Accessed March30, 2013. http://www.wame.org/resources/policies#authorship.